SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
Status:
Terminated
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate the efficacy of the treatment in response rate terms.
Otherwise this study wants to evaluate the safety of the treatment.